Epidemiological Features of Pertussis in Hospitalized Patients in Canada, 1991‐1997: Report of the Immunization Monitoring Program–Active (IMPACT)
Clinical Infectious Diseases1999Vol. 28(6), pp. 1238–1243
Citations Over TimeTop 18% of 1999 papers
Scott A. Halperin, Elaine E. L. Wang, Barbara Law, Elaine L. Mills, Rob Morris, Pierre Déry, Marc Lebel, Noni E. MacDonald, Taj Jadavji, Wendy Vaudry, David W. Scheifele, Gilles Delage, Philippe Duclos
Abstract
To assess the morbidity associated with the continued high levels of pertussis, we studied all children or =6 months. Pertussis continues to cause significant morbidity and occasional mortality in Canada, particularly in young infants.
Related Papers
- → Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets(2011)40 cited
- → Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice(2020)35 cited
- → PERTUSSIS IN CHILDREN – CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS IN THE SAMARA REGION(2018)6 cited
- → The activity of purified bordetella pertussis components in murine encephalopathy(1987)6 cited
- → Role of Immunization Registry Data in Pediatric Patients Diagnosed with Bordetella Pertussis(2005)